Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00591240 · ClinicalTrials.gov registry record

A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
338
Enrollment target

NCT00591240: Completed study, sponsored by VA Office of Research and Development.

NCT00591240 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00591240 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
338 participants
Enrollment target

Study Summary

The purpose of this proposal is clinical validation of an electrochemical biochip for rapid pathogen identification and antibiotic susceptibility determination.

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2007-07
Est. Completion 2011-06

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00591240

The ClinicalTrials.gov registry entry for NCT00591240 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00591240 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00591240 about?

NCT00591240 is a clinical study titled "A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection". The purpose of this proposal is clinical validation of an electrochemical biochip for rapid pathogen identification and antibiotic susceptibility determination.

What is the current status of trial NCT00591240?

This trial is currently completed. The enrollment target is 338 participants. The study started on 2007-07. Estimated completion is 2011-06.

Who is sponsoring clinical trial NCT00591240?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.